Close
SAIC Announces First Quarter of Fiscal Year 2025 Results Jun 3, 2024 07:03AM
  • Revenues of $1.85 billion; 0.4% organic growth; organic growth reflects impacts of divestitures
  • Net income of $77 million; Adjusted EBITDA(1) of $166 million or 9.0% of revenues
  • Diluted earnings per share of $1.48; Adjusted diluted earnings per share(1) of $1.92
  • Cash flows provided by operating activities of $98 million; Transaction-adjusted free cash flow(1) of $21 million
  • Net bookings of $2.6 billion; book-to-bill ratio of 1.4
  • Company reaffirms Fiscal... (continue reading...)

Commander Closes the Sale of its Royalty Portfolio for US $4.1 Million Jun 3, 2024 07:00AM

Vancouver, British Columbia--(Newsfile Corp. - June 3, 2024) - Commander Resources Ltd. (TSXV: CMD) ("Commander" or the "Company")has received final approval and satisfied all closing conditions for the royalty purchase agreement as announced on January 25th, 2024. The Company had agreed to sell a portfolio of its royalty interests (the "Transaction") to TMRF Canada Inc., a subsidiary of Taurus Mining Royalty Fund L.P., for total consideration of US $4.1 million in... (continue reading...)


Equinox Gold Announces "Ride to Greenstone" Fundraiser Jun 3, 2024 07:00AM

Vancouver, British Columbia--(Newsfile Corp. - June 3, 2024) - Equinox Gold Corp. (TSX: EQX) (NYSE American: EQX) ("Equinox Gold" or the "Company") today is launching the Ride to Greenstone, an epic 3,634 km bike relay from Vancouver, BC to Geraldton, Ontario, to celebrate the official opening of the Company's new Greenstone Mine.

The focus of the ride is to raise money for the Geraldton District Hospital, which serves a 2,767-km2 region in Northern Ontario including... (continue reading...)


Nickel 28 Announces Receipt of Management Cease Trade Order in Response to Voluntary Application Jun 3, 2024 07:00AM

Toronto, Ontario--(Newsfile Corp. - June 3, 2024) - Nickel 28 Capital Corp. (TSXV: NKL) (FSE: 3JC0) ("Nickel 28" or the "Company") is pleased to announce that, further to its news release dated May 16, 2024, the Ontario Securities Commission, as principal regulator, has granted the Company a management cease trade order ("MCTO") in response to the Company's voluntary application in respect of its delay in filing its audited annual financial statements, management's... (continue reading...)


ATEX Appoints Chris Beer to Board of Directors Jun 3, 2024 07:00AM

Toronto, Ontario--(Newsfile Corp. - June 3, 2024) - ATEX Resources Inc. (TSXV: ATX) ("ATEX" or the "Company") is pleased to announce that Mr. Chris Beer has joined ATEX's Board of Directors (the "Board") effective immediately and will also serve as Chair of the Company's Audit Committee. Concurrently, Mr. Rob Suttie is retiring from the Board to pursue other commitments.

Craig Nelsen, Chairman of ATEX's Board of Directors, commented, "On behalf of ATEX's Board and... (continue reading...)


More Press Releases

View Older Stories

Jun 3, 2024 07:00AM ArrowStream Renews Relationship With International Dairy Queen and Expands to Distribution Partners in Mexico
Jun 3, 2024 07:00AM Avalon Makes Strategic Appointment for Vice-President, Corporate Development
Jun 3, 2024 07:00AM Eagle Royalties Appoints New Chief Financial Officer
Jun 3, 2024 07:00AM Versatrim Announces Partnership With Fittes, Expanding Product Offering
Jun 3, 2024 07:02AM The Top Five Cyber Threats Impacting Every Industry (And How To Avoid Them)
Jun 3, 2024 07:00AM Sierra Rutile to Participate in 121 Mining Investment Conference, New York
Jun 3, 2024 07:00AM Diversified Energy Closes Market Leading Securitized Financing
Jun 3, 2024 07:00AM NXT Announces Fully Subscribed US$2.0 Million Convertible Debenture
Jun 3, 2024 07:01AM Prelude Therapeutics to Participate in Upcoming Healthcare Conferences
Jun 3, 2024 07:00AM Stallion Uranium Closes Sale of Non-Core Uranium Projects in Eastern Athabasca Basin
Jun 3, 2024 07:00AM Fortrea to Present at the Jefferies Global Healthcare Conference
Jun 3, 2024 07:00AM RedHill Announces a New Patent Covering Opaganib in Combination with Immune Checkpoint Inhibitors, Valid Through 2040
Jun 3, 2024 07:00AM Marriott International Announces Three Conversions to Bring Iconic Luxury Properties in the United States into the Marriott Bonvoy Portfolio Later This Summer
Jun 3, 2024 07:00AM PawFury's Presale Raises Over $3 Million, Set To Surpass Pepe and SHIB
Jun 3, 2024 07:00AM Coalesce Capital Announces Key Hires as Firm Continues to Expand Leadership Team
Jun 3, 2024 07:00AM Dominion Energy Announces Closing of Sale of Western Natural Gas Distribution Assets Questar Gas, Wexpro
Jun 3, 2024 07:00AM FibroGen to Present at Goldman Sachs 45th Annual Global Healthcare Conference
Jun 3, 2024 07:00AM PEAK ROCK CAPITAL AFFILIATE COMPLETES PREVIOUSLY ANNOUNCED ACQUISITION OF HUFRIEDYGROUP
Jun 3, 2024 07:00AM Calidi Biotherapeutics Presents CLD-101 Phase 1 Trial Update and Preclinical Data Highlighting RTNova and CLD-201 at 2024 ASCO Annual Meeting
Jun 3, 2024 07:00AM Axsome Therapeutics Supports Alzheimer’s & Brain Awareness Month
Jun 3, 2024 07:00AM At ASCO 2024, Treos Bio Reports Key Survival Results for Chemo-Free Regimen of PolyPEPI1018 Peptide Immunotherapy and Roche’s PD-L1 Inhibitor in Late-Stage Colorectal Cancer
Jun 3, 2024 07:00AM ATHA Energy Commences 2024 Angilak Diamond Drilling Exploration Program
Jun 3, 2024 07:00AM Recurrent Energy Announces Initial Closing of Investment from BlackRock
Jun 3, 2024 07:00AM Xeris Presents New Post Hoc Analysis on Effects of Levoketoconazole (Recorlev®) in Cushing’s Syndrome Patients at ENDO 2024
Jun 3, 2024 07:00AM Osisko Development to Complete Second Deferred Payment Installment in Connection With the Tintic Acquisition
Jun 3, 2024 07:00AM Labcorp Announces New Strategic Service Offerings within Precision Oncology Portfolio
Jun 3, 2024 07:00AM Grey Wolf Therapeutics Presents First Clinical Data for GRWD5769, a First-in-Class ERAP1 Inhibitor, at the 2024 American Society for Clinical Oncology (ASCO) Annual Meeting
Jun 3, 2024 07:00AM Pulsenmore Appoints Len Farris as Chief Commercial Officer to Lead Global Expansion of Breakthrough Home Ultrasound Technology
Jun 3, 2024 07:00AM Pershing Square Holdings, Ltd. Notes the Sale by Pershing Square Capital Management, L.P. of a 10% Common Equity Interest to Strategic Investors
Jun 3, 2024 07:00AM Skye Bioscience to Present at Jefferies Global Healthcare Conference
Jun 3, 2024 07:00AM StateServ Rebrands to Dragonfly Health
Jun 3, 2024 07:00AM EagleRider Motorcycle Rental and Tours Announces New CEO Sebastian Schoepe
Jun 3, 2024 07:00AM Enbridge Completes Acquisition of Questar Gas Company
Jun 3, 2024 07:00AM Quince Therapeutics Receives U.S. FDA Fast Track Designation for EryDex System
Jun 3, 2024 07:00AM Flow Beverage Corp. to Release Second Quarter 2024 Financial Results
Jun 3, 2024 07:00AM Consor Holdings Announces Growth Investment from New Mountain Capital
Jun 3, 2024 07:00AM Graphite One Announces Repricing of Stock Options
Jun 3, 2024 07:00AM International Energy Forum Report Details EV Copper Hurdles
Jun 3, 2024 07:00AM Dunes Point Capital, LP Announces Roofing Services Solutions' Acquisition of West Orange Roofing, LLC
Jun 3, 2024 07:00AM Beyond Cancer Presents First-in-Class Clinical Data Showing an Immunogenic Response in Subjects with r/r Unresectable Solid Tumors Treated with Ultra-High Concentration Nitric Oxide (UNO)
Jun 3, 2024 07:00AM Lithium Drilling Program Commences at East Vallée
Jun 3, 2024 07:00AM Bruker Launches Transformative neofleX™ MALDI-TOF System for Spatial Biology Mass Spec Imaging (MSI) Applications
Jun 3, 2024 07:00AM Gryphon Investors-Backed Thermal Technology Distribution Solutions Acquires Southwest Heater and Controls
Jun 3, 2024 07:00AM Catona Climate to Offer High-Quality Carbon Credits through Integration with GreenLight Solution by Deloitte
Jun 3, 2024 07:00AM Bausch + Lomb Launches Blink™ NutriTears® Clinically Proven Nutritional Supplement for Dry Eyes in the United States
Jun 3, 2024 07:00AM Spruce Biosciences Presented Phase 2 POWER Study Results of Tildacerfont for the Treatment of Polycystic Ovary Syndrome at ENDO 2024
Jun 3, 2024 07:00AM Andreas Nix is the new COO of the ZKW Group
Jun 3, 2024 07:00AM TriSalus Life Sciences Highlights Clinical Data from Phase 1b PERIO-02 Trial, Studying Delivery of Nelitolimod via Pressure-Enabled Drug Delivery in Patients with Hepatocellular Carcinoma or Intrahepa
Jun 3, 2024 07:00AM Ventra Health Appoints Erika Flowers as Chief People Officer
Jun 3, 2024 07:00AM Alzheimer's Association Encourages Americans to Take Charge of Their Brain Health
View Older Stories